- ►annals.org [PDF] RA Mahmoud, GJ Pandina, I Turkoz, C Kosik … - Annals of internal medicine, 2007 - Am Coll Physicians Background: Major depressive disorder has high prevalence, mor- bidity, and
mortality. Inadequate results with antidepressants have prompts addition of a
nonstandard treatment (augmentation ther- apy). ... Objective: To assess ... Cited by 35 - Related articles - BL Direct - All 7 versions
GI Papakostas, RC Shelton, J Smith, M Fava - The Journal of clinical psychiatry, 2007 - cat.inist.fr Objective: To examine the efficacy and overall tolerability of augmentation of
standard antidepressants with atypical antipsychotic agents for
treatment-resistant major depressive disorder. Data Sources: ... Cited by 48 - Related articles - BL Direct - All 3 versions
A McIntyre, A Gendron, A McIntyre, AZ … - Anxiety - interscience.wiley.com This double-blind, placebo-controlled study examined the efficacy and
tolerability of quetiapine in combination with selective serotonin reuptake
inhibitors (SSRIs)/venlafaxine in 58 patients with major depressive ... Cited by 16 - Related articles - BL Direct - All 2 versions
RM Berman, RN Marcus, R Swanink, RD … - The Journal of clinical psychiatry, 2007 - ncbi.nlm.nih.gov OBJECTIVE: To assess the efficacy and safety of aripiprazole versus placebo as
adjunctive treatment to standard antidepressant therapy (ADT) in patients with
major depressive disorder (MDD) who showed an incomplete response to 1 ... Cited by 87 - Related articles - BL Direct - All 5 versions
DL Dunner, JD Amsterdam, RC Shelton, A … - The Journal of clinical psychiatry, 2007 - ncbi.nlm.nih.gov OBJECTIVE: To evaluate the efficacy and tolerability of adjunctive ziprasidone
in subjects with treatment-resistant major depressive disorder (DSM-IV criteria)
without psychotic features. METHOD: Subjects not responding to selective ... Cited by 20 - Related articles - BL Direct - All 5 versions
ME Thase, SA Corya, O Osuntokun, M Case, … - The Journal of clinical psychiatry, 2007 - ncbi.nlm.nih.gov OBJECTIVE: Two parallel, 8-week double-blind studies compared
olanzapine/fluoxetine combination, olanzapine, and fluoxetine in outpatients
with treatment-resistant depression (TRD). METHOD: Treatment-resistant ... Cited by 44 - Related articles - BL Direct - All 3 versions
RC Shelton, GI Papakostas - Acta Psychiatrica Scandinavica, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 18 - Related articles - BL Direct - All 4 versions
KN Sokolski - The Annals of Pharmacotherapy, 2008 - Harvey Whitney Books Author information provided at the end of the text. ... 1124 I The Annals of
Pharmacotherapy I 2008 July/August, Volume 42 ... Adjunctive Aripiprazole for
Bupropion-Resistant Major Depression ... A 60-year-old single white male ... Cited by 7 - Related articles - All 3 versions
GI Keitner, SJ Garlow, CE Ryan, PT Ninan, … - Journal of Psychiatric Research, 2009 - Elsevier Subjects in both treatment groups improved significantly over time. The odds of
remitting were significantly better for patients in the risperidone vs. placebo
arm (OR = 3.33, p = .011). At the end of 4 weeks of treatment 52% of the ... Cited by 8 - Related articles - All 3 versions
